IL13RA2 is being clinically tested as a possible cancer vaccination and CAR-T treatment target as a glioma-specific cell-surface epitope. Functionally, there are two categories of IL-13 receptors ...
(RTTNews) - Mustang Bio, Inc. (MBIO), on Friday announced that it has exited its lease for the manufacturing facility in Worcester, Massachusetts, and sold certain fixed assets, including ...